The Relationship Between Body Mass Index and Sexual Function in Endometrial Cancer

Rubi M. Garcia

Alexandra Hanlon

William Small

Jonathan B. Strauss

Lillie Lin

Jessica Wells

Deborah W. Bruner

endometrial cancer, body mass index, Female Sexual Function Index, sexual dysfunction
ONF 2018, 45(1), 25-32. DOI: 10.1188/18.ONF.25-32

Objectives: To explore the association between pretreatment body mass index (BMI) and post-treatment sexual function in women treated for endometrial cancer.

Sample & Setting: 28 postmenopausal women treated with vaginal brachytherapy (VBT) took part in this multisite exploratory secondary analysis at the University of Pennsylvania and Northwestern University.

Methods & Variables: Secondary data analysis was used to determine if pretreatment BMI is associated with post-VBT sexual function in postmenopausal women treated for endometrial cancer at baseline and at six months post-treatment. Because of small sample size, participants were dichotomized according to enrollment BMI: 30 or greater (obese) and less than 30 (non-obese). The Female Sexual Function Index was used to assess sexual function, with total scores of 26.55 or less indicating sexual dysfunction.

Results: Both groups had poor sexual function at baseline. Although improved function was observed with time, neither group reached a score indicating healthy sexual function.

Implications for Nursing: Understanding factors that influence sexual health in patients with gynecologic cancer can improve post-treatment quality of life.

Members Only
Not a current ONS member or journal subscriber?

Purchase This Article

Receive a PDF to download and print.